English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Johnson & Johnson raises revenue target to $100.8 billion for 2026 after strong first quarter
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

FDA issues draft safety guidance for genome editing therapies on April 14
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Pharma industry enters Q1 earnings season amid increased mergers and acquisitions activity
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Study finds generative AI models struggle with clinical reasoning in diagnosis
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

New model proposes approach for treating chronic nightmares in children
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Study warns of rising teen dependency on AI companions
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Researchers develop method to improve AI-driven protein engineering with large data sets
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Study finds microplastics lab research often does not match real-world exposure

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes